Literature DB >> 31556869

Neonatal septic arthritis: Indian perspective.

Akash Rai1, Debrup Chakladar2, Souravi Bhowmik2, Tanushree Mondal3, Arnab Nandy1, Biplab Maji2, Avijit Hazra4, Rakesh Mondal1.   

Abstract

OBJECTIVE: To delineate the pattern of joint involvement in neonatal septic arthritis, assess the prognosis, and determine significant predictors of unfavorable outcome.
METHODS: Subjects were recruited through purposive sampling after obtaining parental consent. A detailed history and examination findings with perinatal data were recorded. Ultrasound and magnetic resonance imaging data of affected joints and blood culture and aspirated joint fluid culture data were recorded along with management received. Cases were followed-up every 3 months from discharge up to minimum 12 months. An unfavorable outcome indicated by permanent joint deformity or restricted range of movement of the affected joint, limb length discrepancy, and persistent joint deformity upon radio imaging at the end of the follow-up period were also included.
RESULTS: The hip joint involvement (59.2%) was the commonest with predominance of the monoarticular pattern of affliction (74.4%). An overall outcome was favorable in 70.3% subjects with prompt diagnosis and management. A delay in seeking treatment was found to be an indicator of unfavorable outcome. In addition, disease detection by ultrasound at presentation predicted unfavorable outcome.
CONCLUSION: Neonatal septic arthritis is a rare disease with predominant hip or knee involvement. Outcome is favorable with early detection and institution of appropriate management. A delay in treatment worsens prognosis.

Year:  2019        PMID: 31556869     DOI: 10.5152/eurjrheum.2019.19030

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


  20 in total

1.  Non-criteria manifestations of antiphospholipid syndrome.

Authors:  D Erkan; M D Lockshin
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

2.  Development of instructional, interactive, multimedia anatomy dissection software: a student-led initiative.

Authors:  Matthew J Inwood; Jamil Ahmad
Journal:  Clin Anat       Date:  2005-11       Impact factor: 2.414

3.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

4.  Assessing print and electronic use of reference/core medical textbooks.

Authors:  Ana G Ugaz; Taryn Resnick
Journal:  J Med Libr Assoc       Date:  2008-04

5.  Clinical and academic use of electronic and print books: the Health Sciences Library System e-book study at the University of Pittsburgh.

Authors:  Barbara L Folb; Charles B Wessel; Leslie J Czechowski
Journal:  J Med Libr Assoc       Date:  2011-07

6.  Introduction of an anatomy eBook enhances assessment outcomes.

Authors:  James D Pickering
Journal:  Med Educ       Date:  2015-05       Impact factor: 6.251

7.  Visual research in clinical education.

Authors:  Jeff Bezemer
Journal:  Med Educ       Date:  2016-10-27       Impact factor: 6.251

8.  Radiology education 2.0--on the cusp of change: part 1. Tablet computers, online curriculums, remote meeting tools and audience response systems.

Authors:  Puneet Bhargava; Amanda E Lackey; Sabeen Dhand; Mariam Moshiri; Kedar Jambhekar; Tarun Pandey
Journal:  Acad Radiol       Date:  2013-03       Impact factor: 3.173

9.  Excellence in clinical teaching: knowledge transformation and development required.

Authors:  David M Irby
Journal:  Med Educ       Date:  2014-08       Impact factor: 6.251

10.  The interrupted learner: How distractions during live and video lectures influence learning outcomes.

Authors:  Andrew H Zureick; Jesse Burk-Rafel; Joel A Purkiss; Michael Hortsch
Journal:  Anat Sci Educ       Date:  2017-11-27       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.